The 90 day tariff hiatus has led to a joyous bounce for stocks. We are now half way between the lows and the highs which is a nice balancing act. I sense there is no resistance for more upside til we hit the 200 day moving average for the S&P 500 (SPY – Get Rating) at 5,748. [...]

Pfizer (PFE) has announced a major deal with 3SBio, in-licensing the global development and commercialization rights (excluding China) for SSGJ-707, a bispecific antibody targeting PD-1 and VEGF. This partnership marks a significant step in Pfizer’s oncology pipeline, expanding its efforts in immunotherapy for cancer treatments. SSGJ-707’s Potential in Cancer Treatment 3SBio has been developing SSGJ-707 [...]